Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study
SCT200（一种抗EGFR单克隆抗体）在氟尿嘧啶、伊立替康和奥沙利铂耐药的RAS和BRAF野生型转移性结直肠癌患者中的疗效、安全性和基因组分析：一项Ⅱ期研究
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2024.104966
Yang, Lin; Zhang, Wen; Fan, Nanfeng; Cao, Peiguo; Cheng, Ying; Zhu, Lingjun; Luo, Suxia; Zong, Hong; Bai, Yuxian; Zhou, Jianfeng; Deng, Yanhong; Ba, Yi; Liu, Tianshu; Aili, Mayinuer; Yin, Xianli; Gu, Kangsheng; Dai, Guanghai; Ying, Jieer; Shi, Jianhua; Gao, Yajie; Li, Wei; Yu, Guohua; Xie, Liangzhi; Gai, Wenlin; Wang, Yan; Meng, Peng; Shi, Yuankai
单克隆抗体
肿瘤
肠癌
肿瘤免疫
EGF
BRAF
EGFR
RAS
